About
Cell Therapy, CAR-T
Areas of Focus
Categories
Stem Cell & Cellular Therapy
Team (14)
Dr. Marco PurbhooHead of Translational Medicine
Head of Translational Medicine
MiNK Therapeutics
team_member
Dr. Nils RudqvistSenior Director, Research
Senior Director, Research
MiNK Therapeutics
team_member
Garo Armen,Ph.D.Chairman
Chairman
MiNK Therapeutics
board_chair
Jenny Gumperz,Ph.D.Scientific Advisor
Scientific Advisor
MiNK Therapeutics
advisor
Lydia Lynch,Ph.D.Scientific Advisor
Scientific Advisor
MiNK Therapeutics
advisor
Manuel Hidalgo, M.D., Ph.D.Scientific Advisor
Scientific Advisor
MiNK Therapeutics
advisor
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
67
By Phase
PHASE1: 2PHASE1/PHASE2: 1
By Status
COMPLETED: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2019
2020
2021
2022
2023
2024
2025
Today
Hover over trial bars to see details
Recent Trials
NCT05108623Lead Sponsor
A Study Investigating agenT-797 in Participants With Relapsed/Refractory Solid Tumors
PHASE1Completed
34 participants
Started: Jan 28, 2022 · Completed: Jan 2, 2024
NCT04754100Lead Sponsor
agenT-797 in Participants With Relapsed/Refractory Multiple Myeloma
PHASE1Completed
13 participants
Started: Mar 29, 2021 · Completed: May 31, 2023
NCT04582201Lead Sponsor
Evaluate the Safety of agenT-797 in Participants With Moderate to Severe Difficulty Breathing Secondary to SARS-CoV-2
PHASE1/PHASE2Completed
20 participants
Started: Sep 21, 2020 · Completed: Apr 23, 2023
Locations (1)
Headquarters
Cambridge, UK
Map
Loading map...